Edgewise Therapeutics price target raised to $57 from $45 at H.C. Wainwright
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
H.C. Wainwright raises EWTX target to $57 from $45; posted price $45.32; priceChangeSinceSignal -1.5.
Target: $57
Posted price: $45.32
Analyst firm: H.C. Wainwright
Analyst: Lander Egana
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.